Clinical, laboratory and echocardiographic features of patients with ST-elevation myocardial infarction complicated by ventricular arrhythmias: an observational study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262596Keywords:
ST-elevation myocardial infarction, Ventricular tachycardia, Troponin, Left ventricular ejection fraction, Ventricular arrhythmiasAbstract
Background: Early malignant ventricular arrhythmias (VAs) during ST-elevation myocardial infarction (STEMI) significantly contribute to in-hospital mortality but appear to have little impact on long-term prognosis, likely because the arrhythmic substrate is reversed after revascularization.
Methods: The study included 91 patients with STEMI who were admitted to the Grodno State Cardiological Center for treatment between February 2024 and February 2025. Group 1 included 64 patients with STEMI, whereas Group 2 included 29 patients with STEMI and ventricular arrhythmias (sustained VT or VF). All patients underwent clinical, laboratory, and instrumental examinations, including coronary angiography. Statistical analyses were performed using STATISTICA 12.0 software.
Results: Among 29 patients with VAs, six had ventricular fibrillation treated with electrical cardioversion, three had sustained VT, and 20 had episodes of non-sustained VT. According to the results of coronary angiography, 24 patients had undergone percutaneous coronary intervention, and five patients had stenosis of the left main coronary artery; therefore, they underwent coronary artery bypass graft operation. Patients with STEMI and ventricular tachyarrhythmias were characterized by a higher prevalence of inferior localization of MI (p=0.001), higher WBCs counts (0.008), higher glucose levels (p=0.008), higher troponin levels (p=0.004), lower left ventricular ejection fraction in both M- and B-modes (p=0.001), and higher contractility index (p=0.001).
Conclusions: These results demonstrates that inflammatory markers, myocardial injury, compromised ventricular function, and metabolic disruptions depict that the pathophysiology of arrhythmias in STEMI patients, highlighting the significance of early observation and timely treatment program to decrease the arrhythmic risk.
References
Alkatib M, Alkotyfan AR, Alshaghel MM, Shamiyeh M. Cardiac arrhythmias in STEMI patients in ICU: study on occurrence in first 48 h and correlation with age, sex, infarction site, and risk factors. Ann Medi Surg. 2023;85(10):4824-9.
Schnur A, Rav Acha M, Loutati R, Perel N, Taha L, Zacks N, et al. Incidence of ventricular fibrillation and sustained ventricular tachycardia complicating non-ST segment elevation myocardial infarction. J Clin Medi. 2024;13(8):2286.
Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. EP Europace. 2014;16(11):1655-73.
Silveira CF, Malagutte KN, Nogueira BF, Reis FM, Rodrigues CD, Rossi DA, et al. Clinical and echocardiographic predictors of left ventricular remodeling following anterior acute myocardial infarction. Clin. 2021;76:e2732.
Sattar Y, Alraies MC. Ventricular Aneurysm 2023. StatPearls; 2025
Foth C, Gangwani MK, Alvey H. Ventricular tachycardia. 2018.
Bhar-Amato J, Davies W, Agarwal S. Ventricular arrhythmia after acute myocardial infarction:‘the perfect storm’. Arrhyth Electrophysiol Rev. 2017;6(3):134.
Byrne RA, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Euro Heart J: Acute Cardiovas Care. 2024;13(1):55-161.
Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. EP Europace. 2014;16(11):1655-73.
Sattler SM, Skibsbye L, Linz D, Lubberding AF, Tfelt-Hansen J, Jespersen T. Ventricular arrhythmias in first acute myocardial infarction: epidemiology, mechanisms, and interventions in large animal models. Fronti Cardiovasc Medi. 2019;6:158.
[Song T, Hui W, Huang M, Guo Y, Yu M, Yang X, Liu Y, Chen X. Dynamic changes in ion channels during myocardial infarction and therapeutic challenges. Int J Mole Sci. 2024;25(12):6467.
Warner MJ, Tivakaran VS. Inferior myocardial infarction. 2017.
[James D, London L. Case report detailing an inferior myocardial infarction, third-degree heart block, and cardiogenic shock. J Emerg Nurs. 2021;47(4):557-62.
Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction. Polish Heart J (Kardiologia Polska). 2013;71(3):260-7.
Hodzic E, Drakovac A, Begic E. Troponin and CRP as indicators of possible ventricular arrhythmias in myocardial infarction of the anterior and inferior walls of the heart. Materia Socio-medi. 2018;30(3):185.
Akin I, Behnes M, Müller J, Forner J, Abumayyaleh M, Mashayekhi K, et al. Prognostic value of cardiac troponin I in patients with ventricular tachyarrhythmias. J Clin Medi. 2022;11(11):2987.
Akin I, Behnes M, Müller J, Forner J, Abumayyaleh M, Mashayekhi K, et al. Prognostic value of cardiac troponin I in patients with ventricular tachyarrhythmias. J Clin Medi. 2022;11(11):2987.
Roberts R, Husain A, Ambos HD, Oliver GC, Cox JR, Sobel BE. Relation between infarct size and ventricular arrhythmia. Heart. 1975;37(11):1169-75.
Frampton J, Ortengren AR, Zeitler EP. Arrhythmias after acute myocardial infarction. Yale J Boil Medi. 2023;96(1):83.
Thygesen K, Nørgaard A, Ravkilde J, Gøtzsche C-O, Søgaard P. Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction: effect of intervention with captopril. Circulation. 1994;90(6):101-7.
Downloads
Published
How to Cite
Issue
Section
